ScholarIQanswers from OpenAlex

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

PaperCitations, authors & open-access status

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) have?

ScholarIQcitation count

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) has 266 citations in the OpenAlex counts ScholarIQ stores.

When was Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) published?

ScholarIQyear

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) has 2010 year in the ScholarIQ index.

What is the open-access status of Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

ScholarIQoa status

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) has bronze oa status in the ScholarIQ index.

What is the DOI of Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

ScholarIQdoi

The DOI for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is on the source record.

What is the PMID of Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

ScholarIQpmid

The PMID for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is on the source record.

What is the OpenAlex record for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)?

ScholarIQopenalex

The OpenAlex for Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial